Cysview Logo

Ordering

How to order Cysview®

Cysview is packaged in a kit that includes:

Tick
One 100 mg vial of Cysview powder.
Tick
One vial adapter.
Tick
One prefilled syringe containing 50 mL diluent for Cysview.
Tick
One syringe plunger.
Tick
One Luer Lock catheter adapter.
Open worksheet

For current customers

We definitely appreciate your business.
To order more Cysview, please email or call toll-free using the information below.

Cysview Customer Service

PhotocureCS@Eversana.com

1-855-CYSVIEW (1-855-297-8439) | 8 AM–7 PM CST Monday–Friday
(Please see holiday schedule at the bottom
of this page.)

Choose option 1 for new orders or to inquire about an existing order or invoice

You will need:

Tick
Description: CYSVIEW 100mg kit.
Tick
Product code: 3001-2.
Tick
NDC#: 10511-3001-2.

For ordering ease, you should have the following:

Tick
Account name.
Tick
Contact name (person who is placing the order).
Tick
Contact phone number.
Tick
Ship to address.
Tick
Purchase order number.
Tick
Photocure account number, if available.

Choose option 2 for other topics

Tick
Medical affairs.
Tick
Requesting clinical information.
Tick
Reporting an adverse event.
Tick
Any product-related requests.
Tick
Lodging a product complaint.

For any additional needs, please contact your Cysview Account Manager. Thank you.

Terms and conditions

Minimum order quantity is 9 kits, unless lower quantity is approved by Photocure Operations Director. Payment terms are 30 days, unless exception is approved by Photocure Finance Director. No returned goods accepted, nor credit memo issued, except for product shipped in error, product damaged in transit or a product recall. Products shipped in error by Photocure, Inc. or products damaged in transit must be reported to Photocure, Inc. within ten (10) working days of receipt and must be returned to Photocure, Inc. within 25 days of receipt. Contact Photocure, Inc. customer service at 855-297-8439 phone or 414-434-6952 fax. Shipping FOB destination by ground standard delivery with prepaid freight passed through to customer. All orders received by 2 pm CST will ship next business day. Customer agrees to pay expediting fee and overnight shipping fee if those services are requested. Late payment interest 1% per month. Check or ACH accepted by contacting Photocure Accounting Manager at 609-627-9309.

EVERSANA holiday schedule - closures 2024

  • Jan 01 New Year's Day

  • Jan 15 Martin Luther King Jr. Day

  • May 27 Memorial Day

  • June 19 Juneteenth Day

  • July 04 Independence Day

  • Sept 02 Labor Day

  • Nov 28 Thanksgiving Day

  • Nov 29 Thanksgiving Friday

  • Dec 24 Christmas Eve

  • Dec 25 Christmas Day

Important safety information about Cysview® (hexaminolevulinate HCI)
Cysview is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer.
Anaphylactoid shock, hypersensitivity reactions, bladder pain, cystitis, and abnormal urinalysis have been reported after administration of Cysview.
The most common adverse reactions seen in clinical trials were bladder spasm, dysuria, hematuria, and bladder pain.
Product indication for Cysview® (hexaminolevulinate HCl)

Cysview is an optical imaging agent indicated for use in the cystoscopic detection of carcinoma of the bladder, including carcinoma in situ (CIS), among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy, or in patients undergoing surveillance cystoscopy for carcinoma of the bladder.

Cysview is used with the KARL STORZ D-Light C Photodynamic Diagnostic (PDD) system to perform Blue Light Cystoscopy (BLC®) as an adjunct to White Light Cystoscopy.

Important Risk & Safety Information

Limitations of use
Cysview is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer.

Warnings and precautions
Anaphylactoid shock, hypersensitivity reactions, bladder pain, cystitis, and abnormal urinalysis have been reported after administration of Cysview. The most common adverse reactions seen in clinical trials were bladder spasm, dysuria, hematuria, and bladder pain.

Contraindications
Cysview should not be used in patients with porphyria, gross hematuria, or with known hypersensitivity to hexaminolevulinate or any derivative of aminolevulinic acid. Cysview may fail to detect some malignant lesions. False-positive fluorescence may occur due to inflammation, cystoscopic trauma, scar tissue, previous bladder biopsy, and recent BCG therapy or intravesical chemotherapy. No specific drug interaction studies have been performed.

Use in specific populations
Safety and effectiveness have not been established in pediatric patients. There are no available data on Cysview use in pregnant women. Adequate reproductive and developmental toxicity studies in animals have not been performed. Systemic absorption following administration of Cysview is expected to be minimal. There are no data on the presence of hexaminolevulinate in human or animal milk, the effects on a breastfed infant, or the effects on milk production. The development and health benefits of breastfeeding should be considered along with the mother's clinical need for Cysview and any potential adverse effects on the breastfed infant from Cysview or from the underlying maternal condition.

Use of the KARL STORZ D-Light C Photodynamic Diagnostic (PDD) system
Cysview is approved for use with the KARL STORZ D-Light C Photodynamic Diagnostic (PDD) system. For system set up and general information for the safe use of the PDD system, please refer to the KARL STORZ instruction manuals for each of the components.

Prior to Cysview administration, read the Full Prescribing Information and follow the preparation and reconstitution instructions.